Skip to main content

Table 3 Average cost per woman in € included in the study from the time of inclusion to the end of the follow-up period at delivery

From: Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women

Cost centre Genotyping Controls p value
n = 515 n = 335
Costs relating to RHD - status
 Biological tests - Genotyping, IAT, Kleihauer 268 ± 74 105 ± 49 < 0,001
 Anti-D immunoglobulin injections 136 ± 86 136 ± 57 0.94
 Consultations 187 ± 79 211 ± 76 < 0,001
 Total costs related to RHD status 591 ± 113 452 ± 124 < 0,001
Hospital stay costs
 Hospital admissions during pregnancy 262 ± 910 280 ± 844 0.36
 Delivery 2406 ± 469 2272 ± 477 < 0,001
 Total costs relating to hospital stays 2668 ± 1101 2552 ± 984 0.95